Leap Therapeutics Inc • LPTX

Capital at risk.

About Leap Therapeutics Inc
Ticker
info
LPTX
Trading on
info
NASDAQ
ISIN
info
US52187K2006
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Douglas E. Onsi J.D.
Headquarters
info
47 Thorndike Street, Cambridge, MA, United States, 02141
Employees
info
52
Website
info
leaptx.com
Cypherpunk Technologies Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer. Its lead clinical stage drug candidate includes DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in various ongoing clinical trials for treating esophagogastric and gynecologic cancers, and colorectal cancer. The company also develops FL-501, a monoclonal antibody that inhibits GDF-15 protein that is in preclinical trial. It has an option and license agreement with Adimab, LLC and BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as Leap Therapeutics, Inc. and changed its name to Cypherpunk Technologies Inc. in November 2025. The company was incorporated in 2011 and is based in Cambridge, Massachusetts.
Metrics
BasicAdvanced
Market cap
info
$116M
P/E ratio
info
-
EPS
info
-$1.58
Dividend Yield
info
0.00%
Beta
info
0.09
Forward P/E ratio
info
0
EBIDTA
info
$-62.7M
Ex dividend date
info
-
Price & volume
Market cap
info
$116M
Average daily volume
info
158M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
0.75
Trailing P/E
info
0
Price to sales
info
160.1
Price to book
info
27.25
Earnings
EPS
info
-$1.58
EPS estimate (current quarter)
info
-$0.24
EPS estimate (next quarter)
info
-$0.20
EBITDA
info
$-62.7M
Revenues (TTM)
info
$0.4M
Revenues per share (TTM)
info
$0.00
Technicals
Beta
info
0.09
52-week High
info
$3.58
52-week Low
info
$0.22
50-day moving average
info
$0.56
200-day moving average
info
$0.42
Short ratio
info
0.42
Short %
info
5.76%
Management effectiveness
ROE (TTM)
info
-183.72%
ROA (TTM)
info
-77.23%
Profit margin
info
0.00%
Gross profit margin
info
$1.5M
Operating margin
info
0.00%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
0.00%
Share stats
Outstanding Shares
info
56.7M
Float
info
30.4M
Insiders %
info
11.91%
Institutions %
info
28.71%
Analyst Insights & forecasts
info

0% Buy

100% Hold

0% Sell

Based on information from 1 analysts.

Average price target

info
$3.00
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.37
-$0.36
-2.78%
Q4 • 24Missed
-$0.37
-$0.38
2.63%
Q1 • 25Beat
-$0.40
-$0.42
4.76%
Q2 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0M
$-16.6M
-∞%
Q2 • 25
$0.2M
$-26M
-12,425.36%
Q3 • 25
∞%
56.04%
NaN%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$20M
$14.3M
71.47%
Q2 • 25
$11.4M
$8.7M
76.36%
Q3 • 25
-43.12%
-39.24%
6.83%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-14.5M
-
$-0.1M
$-14.5M
Q2 • 25
$-16.3M
-
$0.2M
$-18.3M
Q3 • 25
12.47%
-
-278.99%
26.22%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Leap Therapeutics Inc share?
Collapse

Leap Therapeutics Inc shares are currently traded for undefined per share.

How many shares does Leap Therapeutics Inc have?
Collapse

Leap Therapeutics Inc currently has 56.7M shares.

Does Leap Therapeutics Inc pay dividends?
Collapse

No, Leap Therapeutics Inc doesn't pay dividends.

What is Leap Therapeutics Inc 52 week high?
Collapse

Leap Therapeutics Inc 52 week high is $3.58.

What is Leap Therapeutics Inc 52 week low?
Collapse

Leap Therapeutics Inc 52 week low is $0.22.

What is the 200-day moving average of Leap Therapeutics Inc?
Collapse

Leap Therapeutics Inc 200-day moving average is $0.42.

Who is Leap Therapeutics Inc CEO?
Collapse

The CEO of Leap Therapeutics Inc is Douglas E. Onsi J.D..

How many employees Leap Therapeutics Inc has?
Collapse

Leap Therapeutics Inc has 52 employees.

What is the market cap of Leap Therapeutics Inc?
Collapse

The market cap of Leap Therapeutics Inc is $116M.

What is the P/E of Leap Therapeutics Inc?
Collapse

The current P/E of Leap Therapeutics Inc is null.

What is the EPS of Leap Therapeutics Inc?
Collapse

The EPS of Leap Therapeutics Inc is -$1.58.

What is the PEG Ratio of Leap Therapeutics Inc?
Collapse

The PEG Ratio of Leap Therapeutics Inc is 0.75.

What do analysts say about Leap Therapeutics Inc?
Collapse

According to the analysts Leap Therapeutics Inc is considered a hold.